Knowlton R G, Brown V A, Braman J C, Barker D, Schumm J W, Murray C, Takvorian T, Ritz J, Donis-Keller H
Blood. 1986 Aug;68(2):378-85.
The use of DNA markers known as restriction fragment length polymorphisms is a sensitive and informative method of distinguishing patient and allogeneic donor cells after bone marrow transplantation. To apply the test, it is necessary in each case to find DNA probes that display patient-specific and donor-specific bands in Southern transfer hybridization. We have isolated a set of 12 cloned DNAs from highly polymorphic loci by which siblings can usually be distinguished. With just four of these probes, we can expect to distinguish the genotypes of the recipient and a sibling donor in more than 99% of cases (except between identical twins). The availability of many highly polymorphic probes also allows selection of an optimal probe for each case, one that can detect both the patient and donor-specific bands in a single hybridization with maximum resolution and sensitivity. We have applied these probes to the analysis of cells from peripheral blood and bone marrow after transplantation and demonstrated their usefulness in confirming engraftment of donor cells or graft rejection, and in detecting mixed lympho-hematopoietic chimerism.
使用称为限制性片段长度多态性的DNA标记是区分骨髓移植后患者细胞和同种异体供体细胞的一种敏感且信息丰富的方法。为了应用该测试,在每种情况下都有必要找到在Southern转移杂交中显示患者特异性和供体特异性条带的DNA探针。我们从高度多态性位点分离出一组12个克隆的DNA,通过这些DNA通常可以区分兄弟姐妹。仅使用其中四个探针,我们预计在超过99%的病例中(同卵双胞胎除外)能够区分受体和同胞供体的基因型。许多高度多态性探针的可用性还允许为每种情况选择最佳探针,即在一次杂交中以最大分辨率和灵敏度检测患者和供体特异性条带的探针。我们已将这些探针应用于移植后外周血和骨髓细胞的分析,并证明了它们在确认供体细胞植入或移植排斥以及检测混合淋巴细胞造血嵌合体方面的有用性。